Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation

[1]  D. Olive,et al.  Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimen , 2004, Bone Marrow Transplantation.

[2]  Michael Boeckh,et al.  The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. , 2004, Blood.

[3]  J. Madrigal,et al.  Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients , 2003, Bone Marrow Transplantation.

[4]  D. Olive,et al.  Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen , 2003, Leukemia.

[5]  M. Maris,et al.  Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. , 2003, Experimental hematology.

[6]  F. Locatelli,et al.  Immune Reconstitution and Early Infectious Complications Following Nonmyeloablative Hematopoietic Stem Cell Transplantation , 2003, Hematology.

[7]  D. Douek,et al.  Early reconstitution of the T‐cell repertoire after non‐myeloablative peripheral blood stem cell transplantation is from post‐thymic T‐cell expansion and is unaffected by graft‐versus‐host disease or mixed chimaerism , 2003, British journal of haematology.

[8]  H. Sengeløv,et al.  A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors , 2003, Bone Marrow Transplantation.

[9]  Rob J. de Boer,et al.  Thymic output: a bad TREC record , 2003, Nature Immunology.

[10]  M. Maris,et al.  Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  C. Junghanss,et al.  Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture? , 2002, Current opinion in infectious diseases.

[12]  D. Douek,et al.  Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation1 , 2002, Transplantation.

[13]  M. Maris,et al.  Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. , 2002, Blood.

[14]  R. Bouabdallah,et al.  Recovery of Lymphocyte and Dendritic Cell Subsets Following Reduced Intensity Allogeneic Bone Marrow Transplantation , 2002, Hematology.

[15]  B. Bolwell,et al.  Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation , 2001, Bone Marrow Transplantation.

[16]  R. Storb,et al.  Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. , 2001, Blood.

[17]  B. Barlogie,et al.  High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions. , 2001, Blood.

[18]  R. Collins,et al.  Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. , 2001, Blood.

[19]  R. Storb,et al.  Nonmyeloablative hematopoietic cell transplantation. , 2001 .

[20]  N. Goulden,et al.  Functional analysis of the CD8+CD57+ cell population in normal healthy individuals and matched unrelated T‐cell‐depleted bone marrow transplant recipients , 2000, British journal of haematology.

[21]  R. Bouabdallah,et al.  High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation , 2000, Bone Marrow Transplantation.

[22]  N. Schmitz,et al.  Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). , 2000, Blood.

[23]  R. Collins,et al.  Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitution , 2000, The Lancet.

[24]  N. Young,et al.  Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. , 1999, Blood.

[25]  S. Kostense,et al.  Evidence that human CD8+CD45RA+CD27- cells are induced by antigen and evolve through extensive rounds of division. , 1999, International immunology.

[26]  M. Florek,et al.  Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection , 1999, Bone Marrow Transplantation.

[27]  R. Hockett,et al.  T cell receptor gene deletion circles identify recent thymic emigrants in the peripheral T cell pool. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. V. van Lier,et al.  Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. , 1998, Blood.

[29]  P. Ljungman.  Immune reconstitution and viral infections after stem cell transplantation. , 1998, Bone marrow transplantation.

[30]  A. Nagler,et al.  Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. , 1998, Blood.

[31]  M. Rep,et al.  Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells , 1997, The Journal of experimental medicine.

[32]  D. Niederwieser,et al.  Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation. , 1997, Blood.

[33]  K. Sullivan,et al.  Infectious morbidity in long‐term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts , 1997, American journal of hematology.

[34]  M. Boeckh,et al.  Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. , 1996, Blood.

[35]  H. Grosse-wilde,et al.  Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. , 1996, Blood.

[36]  R. Storb,et al.  T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. , 1995, Bone marrow transplantation.

[37]  A. Johannisson,et al.  Phenotype transition of CD4+ T cells from CD45RA to CD45R0 is accompanied by cell activation and proliferation. , 1995, Cytometry.

[38]  C. Mackall,et al.  T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. , 1993, Blood.

[39]  J. Aguado,et al.  [Invasive fungal infections in immunocompromised patients]. , 2007, Revista clinica espanola.

[40]  T. Witte.  Stem Cell transplantation (SCT) for MDS. , 2007 .

[41]  D. Porter,et al.  High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  D. Denning,et al.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  R. Storb,et al.  Non-myeloablative transplants for malignant disease. , 2001, Hematology. American Society of Hematology. Education Program.

[44]  L. Borysiewicz,et al.  The role of CD8+, CD57+ cells in human cytomegalovirus and other viral infections. , 1995, Scandinavian journal of infectious diseases. Supplementum.